Patent extension efforts for Lodine, Relafen, Claritin criticized by Rep. Stark.
This article was originally published in The Tan Sheet
Executive Summary
AMERICAN HOME PRODUCTS' LODINE PATENT EXTENSION EFFORTS CRITICIZED by Rep. Pete Stark (D-Calif.) in a Sept. 24 "Dear Colleague" letter. Stark, who also cited efforts to enact two-year patent extensions for Schering-Plough's non-sedating antihistamine Claritin and SmithKline Beecham's NSAID Relafen, argued that these companies "are hoping that we will force the American public into subsidizing a multimillion dollar special interest `sweetheart' deal in our rush to end the 104th Congress."